Print Page

给 业 界 的 信
 
Update to information on psychiatric disorders for chloroquine and hydroxychloroquine (Letter to Healthcare Professionals) (English only)
 
 
 
附件:
  1. Update to information on psychiatric disorders for chloroquine and hydroxychloroquine (English only)  
Related Information:
The United Kingdom: Hydroxychloroquine and chloroquine: increased risk of cardio... 上载于 2022-02-16
European Union: Update to information on psychiatric disorders for chloroquine a... 上载于 2020-11-28
The United States: FDA cautions against use of hydroxychloroquine or chloroquine... 上载于 2020-06-16
Singapore: Use of hydroxychloroquine (Plaquenil®) in the context of COVID 19: Ri... 上载于 2020-06-03
European Union: COVID-19: reminder of the risks of chloroquine and hydroxychloro... 上载于 2020-05-30
Canada: Chloroquine and hydroxychloroquine can have serious side effects. These ... 上载于 2020-04-27
The United States: Coronavirus (COVID-19) Update: FDA Reiterates Importance of C... 上载于 2020-04-25
European Union: COVID-19: reminder of risk of serious side effects with chloroqu... 上载于 2020-04-24
新加坡卫生科学局: 羟氯喹及氯喹可导致低血糖(给医护专业人员的信，内容为英文) 上载于 2014-12-29
新加坡: 羟氯喹及氯喹可导致低血糖 上载于 2014-12-27
 
back